FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
about
Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant RecipientsFEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study.FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers.Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity.Forced Expiratory Volume in 6 s (FEV6) and FEV1/FEV6 Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV1/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study.Detection of airflow limitation using a handheld spirometer in a primary care setting.The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*Spirometry values for detecting a restrictive pattern in occupational health settings.The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal studyEfficient screening for COPD using three steps: a cross-sectional study in Mexico City.Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?Predictors of poor-quality spirometry in two cohorts of older adults in Russia and Belgium: a cross-sectional study.VitalQPlus: a potential screening tool for early diagnosis of COPD.Reference equations for spirometric indices from a sample of the general adult population in Nigeria.Pathophysiological Factors in the Relationship between Chronological Age and Calculated Lung Age as Detected in a Screening Setting in Community-Dwelling SubjectsScreening for Chronic Obstructive Pulmonary Disease in Smoking Cessation Clinic in France.Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns.Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthmaEstimates of restrictive ventilatory defect in the mining industry. Considerations for epidemiological investigations: a cross-sectional study.Diagnosis of chronic obstructive pulmonary disease in the primary care settingCut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean populationLiving near a Major Road in Beijing: Association with Lower Lung Function, Airway Acidification, and Chronic Cough.Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general populationMulticenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?Angle β of greater than 80° at the start of spirometry may identify high-quality flow volume curves.Which is the Best Screening Strategy for COPD among Smokers in Primary Care?Accuracy and Quality of Spirometry in Primary Care Offices.A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study.A prospective cohort study of pulmonary function during pregnancy in women with and without asthma.FEV(6) as screening tool in spirometric diagnosis of obstructive airway disease.Short-term Evaluation of a Comprehensive Education Program Including Inhaler Training and Disease Management on Chronic Obstructive Pulmonary Disease.[Airflow limitation in Brazilian Caucasians: FEV1/FEV6 vs. FEV1/FVC].Quality of spirometry tests and pulmonary function changes among industrial company workers in Iran: a two-year before-and-after study following an intensive training intervention.Comparison of FEV(3), FEV(6), FEV(1)/FEV(3) and FEV(1)/FEV(6) with usual spirometric indices.Early Detection of Chronic Obstructive Pulmonary Disease in Primary Care.Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS.
P2860
Q28391717-34D79FC0-8712-47AD-BF0B-44C4CAC49CE6Q33640507-BE9F6985-67EB-4521-85EA-A53482D97A80Q33698644-49601E67-4EA8-429F-89CE-DA8852CAEE75Q33917410-5BC0EECA-F804-4B69-9C39-733C91E713C0Q34126983-01105001-A056-4F3A-B3AD-72DBAF03222AQ34162343-EE127A7A-F4F0-4C21-B4DD-2527A32FD0BBQ34503139-7CD980B7-A80D-488A-9B68-59977C23F6E5Q34616477-62748673-CD84-4819-B469-076AC68EA867Q34658507-8C03676C-DC85-4360-8478-3D698E0BC56DQ34700794-5A00805E-4C46-496F-AD64-F697601B7DB7Q34923982-AEED52B3-7918-4DBD-9071-A4F222104408Q35215922-F2F31D37-11DB-4AE9-B15E-374FD0B3FEB1Q35216250-76854B09-DCBB-4BAD-BD73-EA340452996FQ35616872-5FE4340C-8793-4708-A650-AFC87C1DDAA1Q35939401-C944453A-8CA7-4E27-9DBD-6B5DB36BDDDEQ35970608-C842A376-3054-4898-86E2-3E1A58D0DC78Q36298785-B6E89D1D-9D82-4AA4-AC94-72451CFD4D4EQ36534745-539B6565-7E7B-4831-90EE-B932EBA076CAQ36812910-9E0A9CFF-F7F3-4774-A263-8CC2FEBD96B7Q36839311-F452F9D7-EC6E-4B88-96C3-9759340AC28DQ36855776-CCB1C043-7A06-46D5-AF22-861FD86FC523Q37029989-811BF2A8-22D3-4B16-85D9-887883409B7BQ37082651-BDF1AE5F-57D3-42FC-AC4B-D93A47B5E93AQ37204207-C771573F-9515-492E-AA60-57902479F052Q37254995-64543CB1-8DE8-4222-BB2D-9E4EEA1F6599Q37312718-60244182-572A-4518-8EB2-A438B11EB224Q38638545-9BBC14D1-77BE-418C-8C14-A2BD536F6694Q39144988-C3EE74AE-EA2A-49B3-9FD9-22B24CE573BBQ39232529-319944C2-6B10-478E-A5DC-12302A2EF22BQ39419824-48428221-55FF-4AFA-8E8B-459244F5B096Q39565310-11519C71-177B-488E-BE3B-A3423408E6F1Q40734339-5E2A493E-A2BD-41EF-A70B-3ADD856619B3Q41366136-60C65B0A-EE40-4D96-876A-6696746C97EFQ41515322-97801700-00F4-41AA-AAA5-7928B9F49A64Q41658393-27EFC8FA-671C-44A0-BAF4-931F21183536Q44364948-40587A43-678A-41AB-8B8E-AE965DA08D3FQ45905213-2B5F3382-ED65-4B98-AD8B-3A3BE899D8F1Q45913888-7E7ACABE-44AB-44BD-AF4B-BA62C984E16CQ47144291-2EB740D1-3FD6-4322-A881-2AC0A5ED534EQ47648367-12956B9B-8F34-46D8-ABA7-FACBCFB64F61
P2860
FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@en
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@nl
type
label
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@en
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@nl
prefLabel
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@en
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@nl
P2093
P356
P1433
P1476
FEV1/FEV6 and FEV6 as an alter ...... y obstruction and restriction.
@en
P2093
Daniel Schuermans
Jan Kartounian
Jan Vandevoorde
Sylvia Verbanck
Walter Vincken
P304
P356
10.1378/CHEST.127.5.1560
P407
P577
2005-05-01T00:00:00Z